Do you want to read an article? Please log in or register.
Long-term follow-up of antivascular endothelial growth factor treatment for diabetic macular oedema: a four-year real-world study
Macular Diseases
Related content
Macular Diseases
Ranibizumab for the Treatment of Diabetic Macular Oedema in the Real-World Clinical Setting in Portugal: A Multicentre Study
Ophthalmologica.
Farinha C, Martins A, Neves A, Soares R, Ruão M, Ornelas M, Neves P, Gomes Rodrigues F, Coelho C, Silva R
doi: 10.1159/000489046.
COMMENTED
Macular DiseasesRetinal Diseases
IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA
Retina.
Wirth MA, Wons J, Freiberg FJ, Becker MD, Michels S
doi: 10.1097/IAE.
Macular Diseases
Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema
Am J Ophthalmol.
Felfeli T, Juncal VR, Hillier RJ, Mak MY, Wong DT, Berger AR, Kohly RP, Kertes PJ, Eng K, Boyd SR, Altomare F, Giavedoni LR, Muni RH
doi: 10.1016/j.ajo.
Macular DiseasesRetinal Diseases
Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser
Br J Ophthalmol.
Gale R, Pikoula M, Lee AY, Denaxas S, Egan C, Tufail A, Taylor P, UK EMR Users Group.
doi: 10.1136/bjophthalmol-2020-315836.
COMMENTED
Macular DiseasesRetinal Diseases
INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Retina.
Vazquez-Alfageme C, Nicholson L, Hamilton RD, Patel PJ
doi: 10.1097/IAE.
RECOMMENDED
Macular Diseases
Changes in real-world treatment patterns for diabetic macular oedema from 2009-2019 and five-year outcomes: Data from the Fight Retinal Blindness! Registry
★ 1
Recommended by
Prof. Dr emer. Josef Flammer, Faculty Member
doi: 10.1111/ceo.13781.
Macular Diseases
Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice
Am J Ophthalmol.
Holekamp NM, Campbell J, Almony A, Ingraham H, Marks S, Chandwani H, Cole AL, Kiss S
doi: 10.1016/
RECOMMENDED
Macular Diseases
Better visual outcome at 1 year with antivascular endothelial growth factor treatment according to treat-and-extend compared with pro re nata in eyes with neovascular age-related macular degeneration
Acta Ophthalmol.
Aurell S, Sjövall K, Paul A, Morén Å, Granstam E
doi: 10.1111/aos.13989.
COMMENTED
Macular Diseases
Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting
Am J Ophthalmol.
Maggio E, Sartore M, Attanasio M, Maraone G, Guerriero M, Polito A, Pertile G
doi: 10.1016/j.ajo.2018.08.004.